Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SkinHealth Systems Inc.SKIN · Entity 6863 | Chief Financial Officer | August 10, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SkinHealth Systems Inc.
Report date August 10, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,955,280 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Tax withholding · Disposed 32,357 · Balance 1,955,280 F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Casper Sleep Inc.
Report date January 25, 2022 · Filed January 26, 2022
Section 16 reporting ended · disclosed 2022-01-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-01-25 transaction · row 1
1 source rowRow 1 · 2022-01-25 · Disposition to issuer · Disposed 187,922 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes. F2: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $8.08 · Expires 2030-09-13 | Direct | 0 |
Reported balance
After 2022-01-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-01-25 · Disposition to issuer · Disposed 234,000 · Balance 0 F4: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F3: The options provided for vesting as to (i) 25% on September 13, 2021; (ii) 25% on September 13, 2022, (iii) 25% on September 13, 2023 and (iv) 25% on September 13, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes.
F2: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award.
F3: The options provided for vesting as to (i) 25% on September 13, 2021; (ii) 25% on September 13, 2022, (iii) 25% on September 13, 2023 and (iv) 25% on September 13, 2024.
F4: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger.
NUTRI SYSTEM INC /DE/
Report date March 08, 2019 · Filed March 11, 2019
Section 16 reporting ended · disclosed 2019-03-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2019-03-08 · Disposition to issuer · Disposed 110,625 · Balance 0 F1: This amount includes 10,202 shares of Issuer Common Stock subject to restricted stock awards that, subject to the terms of the Issuer's Amended and Restated 2008 Long-Term Incentive Plan, as amended (the "Plan") and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F2: This amount includes 21,368 shares of Issuer Common Stock subject to PRSUs that, subject to the terms of the Plan and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 6,259 |
Reported balance
After 2019-03-08 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2019-03-08 · Grant · Acquired 6,259 · Balance 6,259 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Common StockSEC Table I · non-derivative | Direct | 20,202 |
Reported balance
After 2019-03-08 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2019-03-08 · Grant · Acquired 20,202 · Balance 20,202 F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. |
| Common StockSEC Table I · non-derivative | Direct | 19,924 |
Reported balance
After 2019-03-08 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2019-03-08 · Grant · Acquired 19,924 · Balance 19,924 F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $20.94 · Expires 2023-01-04 | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-08 · Disposition to issuer · Disposed 6,259 · Balance 0 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-08 · Disposition to issuer · Disposed 20,202 · Balance 0 F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. |
| Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-08 · Disposition to issuer · Disposed 19,924 · Balance 0 F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This amount includes 10,202 shares of Issuer Common Stock subject to restricted stock awards that, subject to the terms of the Issuer's Amended and Restated 2008 Long-Term Incentive Plan, as amended (the "Plan") and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4.
F2: This amount includes 21,368 shares of Issuer Common Stock subject to PRSUs that, subject to the terms of the Plan and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4.
F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement);
F4: Cont'd from Footnote 1: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock.
F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder.
F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value.
F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder.
F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2018 Filed Jan 3, 2018 17:18 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 557 | $52.70 | $29,353.90 |
DisclosureSEC source: 0001209191-18-001133 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,841 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 17:18 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 6,200 | $52.60 | $326,120.00 |
DisclosureSEC source: 0001209191-18-001133 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,398 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 16:17 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 6,335 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001209191-17-054406 · doc4.xml · derivative · entry 4 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,114 Underlying: Common Shares · 6,335 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 16:17 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 5,000 | $55.03 | $275,128.50 |
DisclosureSEC source: 0001209191-17-054406 · doc4.xml · nonDerivative · entry 3 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,598 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.0090 to $55.0500, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 16:17 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 6,335 | $55.03 | $348,620.12 |
DisclosureSEC source: 0001209191-17-054406 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,598 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.0090 to $55.0500, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 16:17 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 6,335 | $8.88 | $56,254.80 |
DisclosureSEC source: 0001209191-17-054406 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2017 Filed Sep 5, 2017 16:11 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 10,000 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001209191-17-051265 · doc4.xml · derivative · entry 3 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,449 Underlying: Common Shares · 10,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2017 Filed Sep 5, 2017 16:11 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 10,000 | $53.33 | $533,340.00 |
DisclosureSEC source: 0001209191-17-051265 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,598 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.6834 to $54.3000, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2017 Filed Sep 5, 2017 16:11 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 10,000 | $8.88 | $88,800.00 |
DisclosureSEC source: 0001209191-17-051265 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 16:13 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 5,000 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001209191-17-040475 · doc4.xml · derivative · entry 4 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,449 Underlying: Common Shares · 5,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 16:13 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 5,000 | $51.14 | $255,699.00 |
DisclosureSEC source: 0001209191-17-040475 · doc4.xml · nonDerivative · entry 3 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,598 F2 · kind: Sale pursuant to a 10(b)5-1 plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.0000 to $51.2250, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 16:13 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 5,000 | $8.88 | $44,400.00 |
DisclosureSEC source: 0001209191-17-040475 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 24, 2017 16:52 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 3,403 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001209191-17-035014 · doc4.xml · derivative · entry 5 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,449 Underlying: Common Shares · 3,403 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 24, 2017 16:52 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 1,597 | $0.00 Strike: $14.95 | $0.00 |
DisclosureSEC source: 0001209191-17-035014 · doc4.xml · derivative · entry 4 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,852 Underlying: Common Shares · 1,597 shares Expires 2021-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 24, 2017 16:52 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 5,000 | $50.03 | $250,132.00 |
DisclosureSEC source: 0001209191-17-035014 · doc4.xml · nonDerivative · entry 3 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,146 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 24, 2017 Filed May 24, 2017 16:52 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 3,403 | $8.88 | $30,218.64 |
DisclosureSEC source: 0001209191-17-035014 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 24, 2017 16:52 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 1,597 | $14.95 | $23,875.15 |
DisclosureSEC source: 0001209191-17-035014 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed May 24, 2017 16:51 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 3,049 | $49.55 | $151,077.95 |
DisclosureSEC source: 0001209191-17-035011 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,146 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| May 03, 2017 Filed May 5, 2017 16:07 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 3,957 | $0.00 Strike: $14.95 | $0.00 |
DisclosureSEC source: 0001209191-17-030287 · doc4.xml · derivative · entry 5 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,449 Underlying: Common Shares · 3,957 shares Expires 2021-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2017 Filed May 5, 2017 16:07 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 1,043 | $0.00 Strike: $18.98 | $0.00 |
DisclosureSEC source: 0001209191-17-030287 · doc4.xml · derivative · entry 4 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,406 Underlying: Common Shares · 1,043 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2017 Filed May 5, 2017 16:07 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 5,000 | $50.56 | $252,778.00 |
DisclosureSEC source: 0001209191-17-030287 · doc4.xml · nonDerivative · entry 3 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,195 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.0950 to $51.3000, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 03, 2017 Filed May 5, 2017 16:07 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 3,957 | $14.95 | $59,157.15 |
DisclosureSEC source: 0001209191-17-030287 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2017 Filed May 5, 2017 16:07 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 1,043 | $18.98 | $19,796.14 |
DisclosureSEC source: 0001209191-17-030287 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 5,000 | $0.00 Strike: $18.98 | $0.00 |
DisclosureSEC source: 0001209191-17-026682 · doc4.xml · derivative · entry 3 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,449 Underlying: Common Shares · 5,000 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 5,000 | $54.07 | $270,355.00 |
DisclosureSEC source: 0001209191-17-026682 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,195 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.90 to $54.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 5,000 | $18.98 | $94,900.00 |
DisclosureSEC source: 0001209191-17-026682 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 17:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 664 | $53.95 | $35,822.80 |
DisclosureSEC source: 0001209191-17-022336 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,195 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:22 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 6,260 | $0.00 Strike: $20.94 | $0.00 |
DisclosureSEC source: 0001209191-17-018735 · doc4.xml · derivative · entry 4 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,449 Underlying: Common Shares · 6,260 shares Expires 2023-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:22 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 13,000 | $48.58 | $631,575.10 |
DisclosureSEC source: 0001209191-17-018735 · doc4.xml · nonDerivative · entry 3 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,859 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.40 to $49.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:22 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 6,260 | $48.14 | $301,355.77 |
DisclosureSEC source: 0001209191-17-018735 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,859 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.10 to $48.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:22 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 6,260 | $20.94 | $131,084.40 |
DisclosureSEC source: 0001209191-17-018735 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Jun 16, 2017 16:13 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon stock | 13,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040475 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,598 F1 · security: Restricted stock units were granted upon the achievement of certain specified performance goals and will vest, subject to continued employment, on December 31, 2017. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:34 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 828 | $36.75 | $30,429.00 |
DisclosureSEC source: 0001209191-17-002662 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,859 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 17:17 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon stock | 10,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001188 · doc4.xml · nonDerivative · entry 2 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,687 F2 · shares: Restricted shares were granted on January 3, 2017. Shares vest over three years in equal installments on January 3rd of each year. Price per share on day of grant is $35.10. F2 · price: Restricted shares were granted on January 3, 2017. Shares vest over three years in equal installments on January 3rd of each year. Price per share on day of grant is $35.10. Read SEC document |
| January 02, 2017 Filed Jan 4, 2017 17:17 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 709 | $34.65 | $24,566.85 |
DisclosureSEC source: 0001209191-17-001188 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,003 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 17:46 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 10,000 | $34.34 | $343,400.00 |
DisclosureSEC source: 0001209191-16-149837 · doc4.xml · nonDerivative · entry 1 MONAHAN MICHAEL P. · CIK 0001577151 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,712 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.30 to $34.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.